Chemoradiotherapy in Unresectable Esophageal Cancer
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This phase I/II clinical study is designed to evaluate the 1 year local tumor control rate of
chemoradiotherapy using albumin-bound paclitaxel and cisplatin in unresectable esophageal
squamous cell carcinomas based on Nutritional Risk Screening NRS2002.